Epigenetic modification of the FMR1 gene in fragile X syndrome is associated with differential response to the mGluR5 antagonist AFQ056. (Q34157712): Difference between revisions

From Wikidata
Jump to navigation Jump to search
QuickStatementsBot (talk | contribs)
Added qualifier: series ordinal (P1545): 13, #quickstatements; #temporary_batch_1539036243505; invoked by sourcemd_batch_processing on behalf of User:Daniel Mietchen (batch 738)
QuickStatementsBot (talk | contribs)
Removed claim: author name string (P2093): Jacques S Beckmann, #quickstatements; #temporary_batch_1539036243505; invoked by sourcemd_batch_processing on behalf of User:Daniel Mietchen (batch 738)
Property / author name string
Jacques S Beckmann
 
Property / author name string: Jacques S Beckmann / rank
Normal rank
 
Property / author name string: Jacques S Beckmann / qualifier
 
Property / author name string: Jacques S Beckmann / reference
stated in: Europe PubMed Central
PubMed publication ID: 21209411
retrieved: 31 July 2017
Timestamp+2017-07-31T00:00:00Z
Timezone+00:00
CalendarGregorian
Precision1 day
Before0
After0
 

Revision as of 15:37, 9 October 2018

scientific article
Language Label Description Also known as
English
Epigenetic modification of the FMR1 gene in fragile X syndrome is associated with differential response to the mGluR5 antagonist AFQ056.
scientific article

    Statements

    Epigenetic modification of the FMR1 gene in fragile X syndrome is associated with differential response to the mGluR5 antagonist AFQ056. (English)
    0 references
    0 references
    0 references
    0 references
    0 references
    Sébastien Jacquemont
    Maria Giulia Torrioli
    Elizabeth Berry-Kravis
    Baltazar Gomez-Mancilla

    Identifiers